Partnership between Camgenium and Cardiac Tech advances post-surgery heart protection using Pace-Protect system technology
Pace-Protect: Revolutionizing Temporary Pacemaker Management
The medical field is abuzz with excitement over a new development aimed at improving patient outcomes following open-heart surgery – the Pace-Protect device. This innovative pacing lead technology offers real-time cardiac monitoring and alert functions, addressing the unmet need for safer temporary pacemakers.
Developed by Camgenium in partnership with Cardiac Tech, Pace-Protect is a bioadhesive device that securely integrates with the heart tissue, enabling reliable ventricular pacing post-surgery. This groundbreaking technology offers continuous cardiac monitoring, on-demand pacing with lower capture thresholds, and stable performance for at least 14 days post-implantation.
The significance of Pace-Protect lies in its potential to prevent serious adverse events (SAEs) commonly reported following open-heart surgery in the US, with approximately 1,500 SAEs attributed to the management of temporary pacemakers each year. By providing real-time data for clinical monitoring and prompt alerts, Pace-Protect could significantly improve patient safety and outcomes.
Traditional temporary pacing leads used during open-heart surgery often face challenges such as lead dislodgement or failure to maintain effective pacing after a short period. Pace-Protect addresses these issues, offering a more reliable solution for ventricular pacing post-surgery.
The functioning Pace-Protect prototype has been developed to ISO 13485 and IEC 62384 Class IIa standards, ensuring the highest quality and safety. Soft Silicon, a highly sophisticated mesh architecture for communications, has been integrated into the Pace-Protect prototype, providing world-class data security for patient confidentiality and high resilience to ensure individual Pace-Protects never lose contact with the cloud.
Pace-Protect represents the first device using a Soft Silicon mesh network to be deployed in a clinical environment. It monitors all aspects of temporary pacing and reports acute changes immediately to clinicians via a cloud-based platform and app, allowing real-time patient electrogram (EGM) data to be transmitted to the clinical team at high data rates in emergencies.
Camgenium has integrated its proprietary Soft Silicon medical device grade two-way device communications technology for data transmission into the Pace-Protect prototype. The companies are now planning to bring the Pace-Protect prototype into clinical trials, with the potential to revolutionize the management of temporary pacemakers and improve patient outcomes following open-heart surgery.
[1] Camgenium. (2021). Pace-Protect: A bioadhesive pacing lead for the critical post-open-heart surgery period. Retrieved from https://www.camgenium.com/pace-protect
[2] Medgadget. (2021). Pace-Protect: A bioadhesive pacing lead for the critical post-open-heart surgery period. Retrieved from https://www.medgadget.com/2021/03/pace-protect-a-bioadhesive-pacing-lead-for-the-critical-post-open-heart-surgery-period.html
[3] Cardiac Tech. (2021). Pace-Protect: A safer temporary pacemaker. Retrieved from https://www.cardiac-tech.com/pace-protect
[4] Medtronic. (2020). The future of atrial fibrillation management: MRI-compatible pacemakers and remote monitoring. Retrieved from https://www.medtronic.com/uk-en/professionals/resources/articles/the-future-of-atrial-fibrillation-management-mri-compatible-pacemakers-and-remote-monitoring.html
[5] Cleveland Clinic. (2020). Predicting infection risk after cardiac implantable electronic device surgery. Retrieved from https://my.clevelandclinic.org/health/treatments/13790-predicting-infection-risk-after-cardiac-implantable-electronic-device-surgery
- The Pace-Protect device, a revolutionary temporary pacemaker management solution, could significantly contribute to science and health-and-wellness by improving medical-conditions like cardiovascular-health following open-heart surgery, preventing serious adverse events reported annually in the US.
- The innovative Pace-Protect prototype, developed by Camgenium and Cardiac Tech, incorporates advanced technology such as Soft Silicon mesh network and medical-grade two-way device communications, aiming to revolutionize temporary pacemaker management and address the unmet needs in the field of science and health-and-wellness.
- In the future, clinical trials for the Pace-Protect device might contribute to science and health-and-wellness by providing insights into cardiovascular-health during and after open-heart surgery, further addressing the unmet need for safer temporary pacemakers and potentially improving patient safety and outcomes.
